MedPath

CAPSTONE THERAPEUTICS CORP.

CAPSTONE THERAPEUTICS CORP. logo
🇺🇸United States
Ownership
Public
Established
1987-01-01
Employees
47
Market Cap
-
Website
http://www.capstonethx.com

A Study to Evaluate the Safety and Efficacy of Additional Doses of AZX100 Drug Product Following Excision of Keloid Scars

Phase 2
Completed
Conditions
Scar Prevention
Scar Reduction
Interventions
Drug: AZX100 Drug Product
Drug: Placebo
First Posted Date
2009-05-04
Last Posted Date
2012-10-11
Lead Sponsor
Capstone Therapeutics
Target Recruit Count
59
Registration Number
NCT00892723
Locations
🇺🇸

Paddington Testing Company, Inc., Philadelphia, Pennsylvania, United States

🇺🇸

Lotus Clinical Research, Inc., Pasadena, California, United States

🇺🇸

DermResearch, Inc., Austin, Texas, United States

A Study to Evaluate the Safety and Efficacy of AZX100 Drug Product Following Excision of Keloid Scars

Phase 2
Completed
Conditions
Scar Prevention
Scar Reduction
Interventions
Drug: AZX100 Drug Product
Drug: Placebo
First Posted Date
2009-01-21
Last Posted Date
2012-10-11
Lead Sponsor
Capstone Therapeutics
Target Recruit Count
59
Registration Number
NCT00825916
Locations
🇺🇸

DermResearch, Inc., Austin, Texas, United States

🇺🇸

Paddington Testing Company, Inc., Philadelphia, Pennsylvania, United States

A Phase 2a Study to Evaluate the Safety and Efficacy of AZX100 in Trocar Sites of Arthroscopic Shoulder Surgery Patients

Phase 2
Completed
Conditions
Scar Prevention
Scar Reduction
Interventions
Drug: Placebo
First Posted Date
2008-12-19
Last Posted Date
2012-10-11
Lead Sponsor
Capstone Therapeutics
Target Recruit Count
150
Registration Number
NCT00811577
Locations
🇺🇸

Orthopaedics East, PA, Greenville, North Carolina, United States

🇺🇸

Lotus Clinical Research, Inc., Pasadena, California, United States

🇺🇸

Atlas Orthopedics & Sports Medicine, Orlando, Florida, United States

and more 2 locations

A Study to Evaluate the Safety and Effectiveness of Different Doses of Chrysalin in Adults Who Have a Broken Wrist

Phase 2
Terminated
Conditions
Radius Fracture
Interventions
Drug: Placebo
First Posted Date
2005-08-18
Last Posted Date
2010-08-24
Lead Sponsor
Capstone Therapeutics
Target Recruit Count
274
Registration Number
NCT00131482
Locations
🇺🇸

OrthoLogic, Tempe, Arizona, United States

© Copyright 2025. All Rights Reserved by MedPath